Canada will become the first G-20 country in the world to legalize cannabis next July, and few companies are positioned as well as Canopy Growth, which has leading market share in its medical cannabis market. While the company is driving full-speed ahead to capitalize on legalization in Canada, it has pursued several international ventures as well that it expects will ultimately create the most value for shareholders. Join Canopy Growth CEO Bruce Linton as he discusses the company's global opportunities across four continents and then takes questions from participants in this exclusive, limited seating webinar!
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Additional disclosure: Canopy Growth is a client of New Cannabis Ventures, where we provide it with a Investor Dashboard: http://bit.ly/2dM9POB